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ABSTRACT Torpedo californica postsynaptic membrane
fragments were treated with base, which resulted in membranes
that were depleted of many nonacetylcholine receptor poly-
peptides and contained acetylcholine receptor subunits of Mr
40,000, 50,000, 60,000, and 65,000 (Raftery, M. A., Vandlen, R.
L., Reed, K L. & Lee, T. (1975) Cold SpringHarbor Symp. Quant.
BioL 40, 193-202). A 43,000-Mr polypeptide and some other
components were quantitatively extracted. Base-treated mem-
branes retained the capacity to bind [3Hlperhydrohistrionico-
toxin and the local anesthetics dibucaine and tetracaine. The
regulation of this binding by carbamylcholine, as well as the
kinetic mechanism of perhydrohistrionicotoxin binding, was
unchanged. [3H]Perhydrohistrionicotoxin binding activity waslargely reconstituted from 2% sodium cholate extracts of
base-treated membranes. Therefore, the perhydrohistrionico-
toxin binding site appears to be located on one or more of the
acetylcholine receptor polypeptides, and the reconstitution of
that binding site from detergent extracts does not require the
presence of a 43,000-M, polypeptide.
Electrophysiological and biochemical evidence has been pre-
sented that suggests that perhydrohistrionicotoxin (H12-HTX)
interacts with or exerts control over the ion translocation
mechanism(s) of the nicotinic acetylcholine receptor (AcChoR)
of the postsynaptic membrane of the neuromuscular junction
(1-4). We have shown (5) that a radiolabeled derivative,
[3H]H12-HTX, binds to AcChoR-enriched membrane frag-
ments from Torpedo californica in a ratio of 1 mol of [3H]-
H12-HTX bound per 4 mol bound of '25I-labeled a-bungaro-
toxin (a-BuTx) with a dissociation constant of -0.5 ,M. The
H12-HTX site, though distinct, is conformationally linked to
the acetylcholine (AcCho) recognition site, because histrioni-
cotoxin has been shown to increase the affinity of membrane-
bound AcChoR for [3H]AcCho (4) and conversely carbamyl-
choline (Carb) was found to increase the affinity of the mem-
branes for [3H]H12-HTX (5). It has been suggested that the
transition to a state of increased affinity for agonists measured
by biochemical procedures in vitro is analogous to "desensiti-
zation" in vivo, and that H12-HTX acts to block conduction by
converting the AcChoR to a "desensitized" state (4, 6). How-
ever, we found that H12-HTX at a concentration 10-fold greater
than its Kd did not affect the rates of interconversion between
the conformational states of the membrane-bound AcChoR
from Torpedo californica-i.e., states of low and high affinity
for agonists (5). The kinetic evidence of Schimerlik et al. (7)
supports the notion that the final receptor conformations in-
duced by cholinergic agonists on the one hand and by H12-HTX
on the other are different. Another possible mechanism of ac-
tion is a direct blockage of the ion channel when the channel
is in a conducting state (1, 2).
A great deal of recent effort has focused on the identification
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of the H12-HTX binding site. The AcChoR from Torpedo cal-
ifornica purified by affinity chromatography in the detergent
Triton X-100 (8) has been shown to bind AcCho and various
cholinergic ligands (9-11). However, specific [3H]H12-HTX
binding could not be detected in Triton extracts of membrane
fragments (5). Sobel et al. (12) reported that histrionicotoxin
binding could be recovered in the precipitate from Triton X-
100/Berol 043 extracts of Torpedo marmorata membrane
fragments and that this binding activity was associated with a
polypeptide of 43,000 Mr. In contrast, Eldefrawi et al. (13)
chromatographed a Triton extract of Torpedo ocellata mem-
branes on a Sephadex G-200 column and reported a [3H]H12-
HTX binding activity that was separated from [3H]AcCho
binding activity. However, this solubilized binding component
was not shown to be a protein, nor was binding demonstrated
to be specific.
It was recently reported by Neubig et al. (14) that Ac-
ChoR-enriched membranes from Torpedo could be selectively
depleted of the 43,000 Mr polypeptide and some other non-
AcChoR polypeptides by treatment with base. These treated
membranes contained three of the four polypeptides (Mr
40,000, 50,000, and 66,000) characteristic of the isolated puri-
fied AcChoR. These membranes bound a '4C-labeled local
anesthetic analog specifically, and this was displaced by mi-
cromolar concentrations of H12-HTX.
We report here direct binding of [3H]H12-HTX to Ac-
ChoR-enriched membranes purified by rapid sucrose density
gradient centrifugation and then treated with base, as well as
stopped-flow kinetics of H12-HTX binding by using the fluo-
rescent probe ethidium. The reconstitution of [3HIH12-HTX
binding from cholate extracts of these membranes is also re-
ported. The results indicate that the 43,000 Mr polypeptide does
not contain the H12-HTX binding site, but rather that specific
high-affinity H12-HTX binding is associated with the Ac-
ChoR-containing polypeptides of 40,000, 50,000, 60,000, and
65,000 Mr.
MATERIALS AND METHODS
AcChoR-enriched membrane fragments were prepared from
Torpedo californica electroplax by rapid sucrose density gra-
dient fractionation and treated with base (unpublished results).
The concentration of 125I-labeled a-BuTx ('251-a-BuTx) sites
was determined by DEAE-cellulose disc assay (15) using
'25I-a-BuTx prepared from Bungarus multi-cinctus venom
(Sigma) by the procedure of Blanchard et al (16). Protein
concentrations were measured by the method of Lowry et al.
(17). Cholate (2%) extracts of the membranes were prepared
by stirring the membranes at concentrations of 5-30 mg of
protein per ml for 30 min at 0°C with the detergent followed
by centrifugation for 1 hr at 100,000 X g.
Abbreviations: AcCho, acetylcholine; AcChoR, acetylcholine receptor;
a-BuTx, a-bungarotoxin; Carb, carbamylcholine; H12-HTX, perhy-
drohistrionicotoxin.
Proc. Natl. Acad. Sci. USA 76 (1979) 2577
[3HJH12-HTX was prepared and binding to membrane
fragments and cholate extracts was measured by centrifigil
assay or equilibrium dialysis as described (5, 18). Stopped-flow
kinetic measurements were performed as described (19, 20).
Sodium dodecyl sulfate/8.75% acrylamide gel electrophoresis
was carried out in the buffer system of Laemmli (21). Gels were
stained with Coomassie brilliant blue.
RESULTS AND DISCUSSION
Membrane fragments treated at pH 11 in low-ionic-strength
media showed very simple sodium dodecyl sulfate gel elec-
trophoresis patterns. Bands that stained strongly with Coomassie
brilliant blue appeared at 40,000, 50,000, 60,000, and 65,000
Mr [bands identified as subunits of purified AcChoR (11,
22-26)]. Minor components at 90,000 Mr and at apparent
molecular weights less than 40,000 were also present (Fig. 1).
No staining was visible at 43,000 Mr. The specific activity of
these preparations was 2-4 nmol of a-BuTx sites per mg of
protein.
[3H]H12-HTX bound to the treated membranes lacking the
43,000 Mr polypeptide with unchanged stoichiometry and
dissociation constant (Fig. 2). The ability of Carb to regulate
the affinity of the membranes for [3H1H12-HTX was un-
changed; the Kd for untreated membranes was lowered from
1.4 MM to 0.77 MM in the presence of 10MM Carb whereas for
base-treated membranes it changed from 1.4 MM to 0.73 MM.
The values of Kd previously reported for membranes in these
buffer conditions (no Ca2+ or Mg2+ present) are 0.9 MM in the
absence and 0.5 MM in the presence of 10 MM Carb (18).
The local anesthetics dibucaine and tetracaine displaced
[3H]H,2-HTX bound to base-treated membranes with apparent
Kis not significantly different from those determined for un-
treated membranes (unpublished). The apparent Ki for dibu-
caine was 60MuM and for tetracaine, 2 MM (Fig. 3). Carb regu-
lated the affinity of the base-treated membranes for these local
anesthetics. Carb (10 MM) increased the apparent affinity of
the H12-HTX site for dibucaine approximately 17-fold (Ki =
3.5 MM). The reverse effect was seen with tetracaine; its ap-
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FIG. 1. Sodium dodecyl sulfate/polyacrylamide gel electropho-
resis. Lanes: 1, AcChoR purified by affinity chromatography; 2, Ac-
ChoR-enriched membrane fragments; 3, AcChoR-enriched membrane
fragments treated with base; 4, the supernatant from base treatment
of the membranes; 5, a 2%/6 cholate extract of base-treated AcChoR-
enriched membranes.
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FIG. 2. Scatchard plots of [3HJH12-HTX binding to AcChoR-
enriched membranes before (Left) and after (Right) treatment at pH
11 in the presence (0) and absence (0) of 10 MAM Carb. In both ex-
periments the concentration of 1251-a-BuTx sites was 1.91 JAM and
the buffer was 20mM Hepes, pH 7.4/250 mM NaCl/5 mM KCl/0.020%
NaN3. The plots were made by using a linear least-squares fit of the
data.
parent affinity was decreased t1:30 in the presence of 10,uM
Carb (K1 = 60,M). It should be noted that at this concentration
of Carb the membrane-bound AcChoR was essentially fully
converted to the conformational state(s) having high affinity
for agonists (27).
The observed kinetics of H12-HTX binding to membrane-
bound AcChoR were unchanged after alkaline extraction of the
membrane fragments. Under pseudo-first-order conditions the
reaction curve, as monitored by the decay in fluorescence of
the extrinsic probe ethidium, was monophasic: The apparent
rate constant (kapp) of this signal change increased with in-
creasing H12-HTX concentration, and rate limitation occurred
at high ligand concentrations (Fig. 4). This kinetic behavior is
consistent with the mechanism proposed by Schimerlik et al.
(7) in which a rapid equilibration-of H12HTX (L) and AcChoR
(R) is followed by a slow isomerization of the initial com-
plex: K k,
R + L .RLL 'RL*.
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FIG. 3. Displacement of [3H]HI2-HTX bound to base-treated
membranes in the presence (0) and absence (0) of 10,MM Carb by
tetracaine (Left) and dibucaine (Right). The concentration of 1251-
a-BuTx sites was 1.33 ,uM and the concentration of [3H1H12-HTX
was 0.44 MM. The [3HIH12-HTX dissociation constants used to draw
the theoretical curves for competitive inhibition were 0.2MM in the
presence of 10MpM Carb and 0.4MM in its absence. The buffer was 20
mM Hepes, pH 7.4/250 mM NaCl/5 mM KCl/4 mM CaCl2/2 mM
MgCl2/0.02% NaN3. (Left) 0, Ki - 60,MM; *, Ki = 2MM. (Right) O,
Ki = 3.5 ,uM; *, Ki = 60,uM.
Biochemistry: Elliott et al.
Proc. Natl. Acad. Sci. USA 76 (1979)
1.6
1.4
1.2
1.0uh
0
em
4c
0.8
0.6
0.4
0.2
--0
0~~~~~--
o
-1
0 ,-'
0
-I'~~~~~~~~~~I~~~~~~~~~~~
I 1 I
0 2 4 6 8 10
H,2-HTX, pM
12 14
FIG. 4. The effect of H12-HTX concentration on the kinetics of
binding of membrane-bound AcChoR before (-) and after (0) base
treatment. The final concentration of 1251-a-BuTx sites was 0.3 MM
and of ethidium was 2.0 MM. The buffer was the same as in Fig. 3 and
experiments were carried out at 250C. Excitation was at 493 nm and
fluorescence emission was monitored by using a Corning C.S. 3-69
cut-off filter. Each point is the average of at least two determinations,
and the lines are those calculated from a nonlinear regression fit to
the data, which gave values ofK and k 1 equal to 4.6 1.0MM (errors
given are ±SD) and 0.018 + 0.001 s-1 ()or 3.0 + 1.0MM and 0.015
i 0.001 s51 (0), respectively.
According to such a scheme, the apparent rate constant kapp is
given by the relationship:
kap - k1[LJ kjPP K + [LI+k
The observed concentration dependence of kapp (Fig. 4) was
consistent with the relationship, and the values of the kinetic
parameters kI and K were obtained from a nonlinear regression
fit of the data to the above equation by using the value of k
equal to 1.5 X 10-3 s-I estimated by Schimerlik et al. (7). The
best fit values of K for the pre-equilibrium and of kI for the
isomerization were 4.6 + 1.0 MM and 0.018 + 0.001 so1, re-
spectively for H12-HTX binding to AcChoR before alkaline
extraction, and the corresponding values after treatment were
3.0 + 0.7 AM and 0.015 + 0.001 sl. These values are in close
agreement with those previously reported (7) and they were
not significantly affected by variation in the value of k-1 be-
tween 0 and 3 X 10-3 s-1. It therefore appears that the removal
of the 43,000 Mr polypeptide does not affect the kinetics of
H12-HTX binding to AcChoR-enriched membrane frag-
ments.
Because the 43,000 Mr polypeptide was not necessary for
specific binding of H12-HTX, or for binding of the local anes-
thetics tested, to membrane fragments or for Carb regulation
of those binding activities, we investigated the possibility that
it has a structural role. We examined this possibility by deter-
mining whether I3H1H12-HTX binding could be reconstituted
after dissolution of the membranes in 2% cholate (Fig. 5). The
extract of base-treated membranes was diluted from 2% to 0.5%
cholate, a concentration at which [3HJH12-HTX binding was
shown to be completely recovered in extracts of untreated
membranes (18). The extract bound 13,'IHI2-HTX with Kd Ad
2 MM and 0.18 I3HIH12-HTX sites per 125I-cv-}BuTx site. The
previously reported Kd and sites ratio for [3H1H12-1ITX binding
to cholate extracts were 1.6 MM and 0.26, respectively (18).
Thus, [3HIH12-HTX binding was largely, though not com-
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FlG. 5. Binding of [3H1H12-HTX to a 2% cholate extract of
base-treated membrane fragments diluted to 0.5% cholate in the
presence (0) and absence (-) of 40 MM unlabeled H12-HTX. The
concentration of 12531-a-BuTx sites was 1.9 ,uM. The bottom curve (0)
shows a fairly large component of nonspecific binding.
pletely, recovered. The binding of [3H1H12-HTX to extracts of
membranes not treated with base was strongly dependent on
cholate concentration (18). It has not yet been shown whether
such concentration dependence is the same for base-treated
membranes. Thus, the incomplete recovery of H12-HTX
binding sites (~70% recovered) might be a function of a dif-
ferent (lependence on cholate concentration.
CONCLUSIONS
The results reported here eliminate the possibility that the
43,000 Mr polypeptide contains the specific binding site for
1112-HTX of Kd a0.5 AtM and for some local anesthetics such
as dibucaine and tetracaine. Base-treated membranes retain
the capacity to bind [3HIHI2-HTX and the local anesthetics
tested. The regulation of this binding by Carb and the kinetic
mechanism of HI2-HTX binding are unchanged. Additionally,
13H1H]2-HTX binding was largely reconstituted from 2%
cholate extracts of base-treated membranes. Thus, the HI2-HTX
binding site appears to be located on one or more of the AcChoR
polypeptides, and the reconstitution of that binding site from
detergent extracts does not require the presence of a 43,000 Mr
polypeptide.
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